Attorney Daily - Your source for the most important legal news

Archive for May, 2006

Man Diagnosed with Fusarium Keratitis After Using ReNu with MoistureLoc Files Lawsuit Against Bausch & Lomb

Tuesday, May 30th, 2006

Parker & Waichman, LLP Announces It Has Filed Suit on Behalf of Man Diagnosed With Fusarium Keratitis in Left Eye After Using ReNu With MoistureLoc Contact Lens Solution

Victim Underwent Cornea Transplant, Lensectomy, Capsulectomy, Iris Removal and Multiple Flush-Out Surgeries on Left Eye, Awaits FDA Approval for Iris Transplantp> Parker & Waichman, LLP announces that it has filed a suit against Bausch & Lomb, Inc. on behalf of a 53-year-old man who was diagnosed with Fusarium keratitis in his left eye after using ReNu with MoistureLoc. As a result of the infection, the injured man underwent a corneal transplant after several invasive surgical procedures to remove the infection failed. He is currently awaiting FDA approval for an iris transplant. The suit was filed yesterday in the Supreme Court of the State of New York in Onondaga County.

On April 10, 2006 the FDA and the CDC issued public health warnings concerning serious fungal infections associated with contact lens solution use. The CDC stated that it had interviewed 30 patients suspected of having fungal keratitis. Of these 30 patients, 28 wore soft contact lenses and 26 used a Bausch & Lomb ReNu contact lens solution in the month prior to the fungal infection diagnosis. On April 13, 2006 Bausch & Lomb, Inc. recommended that consumers switch to another lens care solution and asked all retailers to remove U.S.-manufactured ReNu with MoistureLoc from their shelves. On May 2, 2006 the CDC announced that the number of confirmed fungal infections rose to 88 cases. Just three days later, on May 5, 2006, the CDC revised the number of confirmed cases to 102.
(more…)

Health Canada Issues Warning of Serious Health Risks Posed By Nasutra, a Non-Prescription Sexual Enhancement Medication

Sunday, May 7th, 2006

Health Canada has issued a warning to consumers not to use the non-prescription product, Nasutra, because “it has been found to contain the undeclared ingredient sildenafil (chemical name for ViagraTM) that could lead to serious health risks, especially for patients with existing medical conditions such as heart problems, those who may be taking heart medications, or those who may be at risk for strokes.”

Although Nasutra is touted as an “all-natural traditional Chinese medicine for sexual enhancement,” it was found to contain sildenafil, “which should only be used under medical supervision.”
(more…)

European Commission Finds Sunscreen Labels Misleading and Potentially Dangerous

Saturday, May 6th, 2006

The European Commission is claiming precisely what pending lawsuits in California are alleging, namely, that sunscreen labels are not only misleading, but potentially dangerous in that they lead consumers to believe that the products protect tem from skin cancer or premature aging when, in fact, the benefit of the products is limited to sunburn protection.

The Commission is concerned with such labeling terms as “sunblocker” that could give consumers the mistaken impression that the products give total protection from the sun’s damaging rays. In fact, no sunscreen product provides complete protection from dangerous UV radiation.
(more…)

© 2008 Attorney Daily | Contributors